TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER
- PMID: 31363335
- PMCID: PMC6629207
- DOI: 10.20471/acc.2019.58.01.17
TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER
Abstract
All transforming growth factors beta (TGFß) are cytokines that regulate several cellular functions such as cell growth, differentiation and motility. They may also have a role in immunosuppression. Their role is important for normal prostate development. TGFß is active in the regulation of balance between epithelial cell proliferation and apoptosis through stromal epithelia via the androgen receptor action. TGFß protects and maintains prostate stem cells, an important population necessary for prostate tissue regeneration. However, TGFß is shown to have a contrasting role in prostate tumor genesis. In the early stages of tumor development, TGFß acts as a tumor suppressor, whereas in the later stages, TGFß becomes a tumor promoter by inducing proliferation, invasion and metastasis. In this review, we outline complex interactions that TGFß-mediated signaling has on prostate tumor genesis, focusing on the role of these interactions during the course of prostate cancer and, in particular, during disease progression.
Keywords: Disease progression; Prostatic neoplasms; Receptors, androgen; Stem cells; Transforming growth factor beta.
Similar articles
-
TGF-beta signalling and immunity in prostate tumourigenesis.Expert Opin Ther Targets. 2010 Feb;14(2):179-92. doi: 10.1517/14728220903544507. Expert Opin Ther Targets. 2010. PMID: 20055717 Review.
-
TGFβ signaling limits lineage plasticity in prostate cancer.PLoS Genet. 2018 May 21;14(5):e1007409. doi: 10.1371/journal.pgen.1007409. eCollection 2018 May. PLoS Genet. 2018. PMID: 29782499 Free PMC article.
-
TGF-betal/Smad signaling in prostate cancer.Curr Drug Targets. 2003 Apr;4(3):197-207. doi: 10.2174/1389450033491118. Curr Drug Targets. 2003. PMID: 12643470 Review.
-
Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.Growth Factors. 1998;16(2):101-10. doi: 10.3109/08977199809002121. Growth Factors. 1998. PMID: 9932228
-
Osteoblast-derived factors promote metastatic potential in human prostate cancer cells, in part via non-canonical transforming growth factor β (TGFβ) signaling.Prostate. 2018 May;78(6):446-456. doi: 10.1002/pros.23489. Epub 2018 Jan 31. Prostate. 2018. PMID: 29383751
Cited by
-
Combination Blockade of the IL6R/STAT-3 Axis with TIGIT and Its Impact on the Functional Activity of NK Cells against Prostate Cancer Cells.J Immunol Res. 2022 Apr 12;2022:1810804. doi: 10.1155/2022/1810804. eCollection 2022. J Immunol Res. 2022. PMID: 35465350 Free PMC article.
-
CORRELATION OF EXPRESSION OF TGF- β AND MMP2 BETWEEN PROSTATIC ADENOCARCINOMA AND ADJACENT UNAFFECTED PARENCHYMA.Acta Clin Croat. 2022 Oct;61(Suppl 3):9-14. doi: 10.20471/acc.2022.61.s3.1. Acta Clin Croat. 2022. PMID: 36938549 Free PMC article.
-
TGF-β and microRNA Interplay in Genitourinary Cancers.Cells. 2019 Dec 12;8(12):1619. doi: 10.3390/cells8121619. Cells. 2019. PMID: 31842336 Free PMC article. Review.
-
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials.Signal Transduct Target Ther. 2022 Jun 24;7(1):198. doi: 10.1038/s41392-022-01042-7. Signal Transduct Target Ther. 2022. PMID: 35750683 Free PMC article. Review.
-
A Review of Prostate Organogenesis and a Role for iPSC-Derived Prostate Organoids to Study Prostate Development and Disease.Int J Mol Sci. 2021 Dec 3;22(23):13097. doi: 10.3390/ijms222313097. Int J Mol Sci. 2021. PMID: 34884905 Free PMC article. Review.
References
-
- American Cancer Society. Cancer Facts & Figures 2009. Atlanta: American Cancer Society, 2009.
-
- Robertson SA, Ingman WV, O’Leary S, et al. Transforming growth factor beta – a mediator of immune deviation in seminal plasma. J Reprod Immunol. 2002;57:109–28. - PubMed
-
- Issacs JT. In benign prostate hyperplasia. Rodgers CH, et al., eds. 1985;Vol 2:85-94.
-
- Russell PJ, Bennett S, Stricker P. Growth factor involvement in progression of prostate cancer. Clin Chem. 1998;44:705–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical